Atlas Trials

The Evaluation of Pharmacokinetic/Pharmacodynamic Characteristics and Safety of QDX in Healthy Korean Male Subjects

Clinical trial NCT04401137 · COMPLETED

Trial details

NCT number
NCT04401137
Sponsor
SK Chemicals Co., Ltd.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Migraine
Start date
2020-07-01
Primary completion
2020-10-06
Enrollment
42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.